Violation Tracker Parent Company Summary

Parent Company Name: 
Novartis
Ownership Structure: 
publicly traded (ticker symbol NVS)
Headquartered in: 
Switzerland
Industry: 
pharmaceuticals
Penalty total since 2010: 
$938,925,285
Number of records: 
15
Top 10 Primary Offense TypesPenalty TotalNumber of Records
off-label/unapproved promotion of medical products$495,000,0002
kickbacks and bribery$390,000,0001
Foreign Corrupt Practices Act$25,000,0001
HHS civil monetary penalties$12,870,0002
export control violation$8,100,0001
economic sanction violation$7,617,1501
wage and hour violation$199,4431
workplace safety or health violation$62,0984
employment discrimination$51,5941
environmental violation$25,0001
Notes: 

Parent-subsidiary linkages are based on relationships current as of the latest revision listed in the Update Log, which may vary from what was the case when a violation occurred. The penalty dollar total above may be adjusted to account for the fact that the list of entries below may include both agency records and settlement announcements for the same case; or else a penalty covering multiple locations may be listed in the individual records for each of the facilities. Duplicate penalty amounts are marked with an asterisk in the list below.

Associated Names: 

ALCON; ALCON PHARMACEUTICALS AND ALCON LABS; NOVARTIS; NOVARTIS VACCINES AND DIAGNOSTICS AND NOVARTIS PHARMACEUTICALS; SANDOZ

Links: 

For an overview of this company's accountability track record, read its Corporate Rap Sheet here.

Subsidy Tracker data on financial assistance to this company by federal, state and local government agencies can be found here.

To see how this company's federal lobbying expenses and campaign contributions compare to its federal subsidies and contracts, check out the Sunlight Foundation's Fixed Fortunes report.


Individual Penalty Records:

Download results as CSV or XML
Company Primary Offense Type Year Agency Penalty Amountsort icon
Novartis Pharmaceuticals Corporation off-label/unapproved promotion of medical products 2010 FDA $422,500,000
Novartis Pharmaceuticals kickbacks and bribery 2015 SDNY $390,000,000
Novartis Vaccines & Diagnostics Inc. and Novartis Pharmaceuticals Corporation off-label/unapproved promotion of medical products 2010 FDA $72,500,000
Novartis AG Foreign Corrupt Practices Act 2016 SEC $25,000,000
Sandoz, Inc. HHS civil monetary penalties 2015 HHSOIG $12,640,000
Alcon Pharmaceuticals Ltd. and Alcon Laboratories, Inc. export control violation 2016 BIS $8,100,000
Alcon Laboratories, Inc economic sanction violation 2016 OFAC $7,617,150
Sandoz, Inc. HHS civil monetary penalties 2011 HHSOIG $230,000
Alcon Research, Ltd. wage and hour violation 2011 WHD $199,443
Novartis Pharmaceuticals employment discrimination 2013 OFCCP $51,594
ALCON RESEARCH, LTD workplace safety or health violation 2010 OSHA $30,300
ALCON INDUSTRIES INC environmental violation 2014 EPA $25,000
ALCON LABORATORIES, INC. workplace safety or health violation 2016 OSHA $16,480
ALCON INDUSTRIES workplace safety or health violation 2014 OSHA $9,240
NOVARTIS CONSUMER HEALTH INC. workplace safety or health violation 2013 OSHA $6,078
Download results as CSV or XML